Aurobindo Pharma Secures USFDA Final Nod for Rivaroxaban 2.5mg – Strong Boost to Global Expansion Strategy!
🌐 Detailed Market Report: Aurobindo Pharma, a leading name in the global pharmaceutical landscape, has received a final approval from…
🌐 Detailed Market Report: Aurobindo Pharma, a leading name in the global pharmaceutical landscape, has received a final approval from…
Aurobindo Pharma Limited, a major pharmaceutical company, has taken a strategic step toward sustainability by acquiring up to 26% stake…
Report on Aurobindo Pharma’s Curateq Share Allotment 1. Key Announcement: Aurobindo Pharma’s wholly owned subsidiary, Curateq Biologics Private Limited, has…